SCHEMBL9538154

SCHEMBL9538154

O=C(Cl)CCC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 4/20 0.50
SLC6A3 Q01959 3/20 0.43
CYP19A1 P11511 2/20 0.42
EPHX2 P34913 5/20 0.42
CACNA1F O60840 2/20 0.42
DRD4 P21917 2/20 0.42
DRD5 P21918 2/20 0.42
HRH2 P25021 2/20 0.42
ADRA1D P25100 2/20 0.42
HTR2A P28223 2/20 0.42
HTR7 P34969 2/20 0.42
ADRA1A P35348 2/20 0.42
HRH1 P35367 2/20 0.42
ADRA1B P35368 2/20 0.42
OPRM1 P35372 2/20 0.42
DRD3 P35462 2/20 0.42
OPRD1 P41143 2/20 0.42
OPRK1 P41145 2/20 0.42
HTR6 P50406 2/20 0.42
CACNA1D Q01668 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67228 0.84 CACNA1B (0.53) CACNA1BSLC6A3CYP19A1EPHX2CACNA1F
SCHEMBL4618760 0.82 MTNR1A (0.48) EPHX2HTR2AHRH1
SCHEMBL2862307 0.81 CACNA1B (0.54) CACNA1BSLC6A3CYP19A1EPHX2CACNA1F
SCHEMBL8109949 0.81 CACNA1B (0.50) CACNA1BSLC6A3CYP19A1EPHX2CACNA1F
SCHEMBL5451594 0.80 LMNA (0.46) CACNA1BCACNA1CFFAR1HDAC3HDAC4
SCHEMBL7323763 0.79 CACNA1B (0.49) CACNA1BSLC6A3CYP19A1EPHX2CACNA1F
Hydrochloric Acid SCHEMBL7389220 0.79 CACNA1B (0.55) CACNA1BSLC6A3CYP19A1EPHX2CACNA1F
SCHEMBL5688113 0.79 CES2 (0.49) CYP19A1HDAC4HDAC7HDAC5
SCHEMBL13130720 0.78 CACNA1B (0.48) CACNA1BSLC6A3CYP19A1EPHX2CACNA1F
SCHEMBL67079 0.77 TBXA2R (0.58) CACNA1BSLC6A3CACNA1FDRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0151826-B1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-31 EP disclosed
US-5137896-A Useful in treatment of gastrointestinal and psychic disorder; analgesic, antiemetic and antiulcer agent JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-11 US disclosed
US-5057525-A Stimulators of gastrointestinal motility JANSSEN PHARMACEUTICA N.V. (BE) 1991-10-15 US disclosed
US-4962115-A Stimulate motility of gastrointestinal system JANSSEN PHARMACEUTICA N.V. (BE) 1990-10-09 US disclosed
US-4839374-A TREATING ALLERGIES JANSSEN PHARMACEUTICA, N.V. (BE) 1989-06-13 US disclosed
US-4695575-A ANTIHISTAMINES JANSSEN PHARMACEUTICA, N.V. (BE) 1987-09-22 US disclosed
EP-0076530-B1 NOVEL N-(3-HYDROXY-4-PIPERIDINYL)BENZAMIDE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1985-12-11 EP disclosed
EP-0076530-A2 Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1983-04-13 EP disclosed